高风险子宫内膜癌中复发性疾病的临床负担

Kalé Kponee-Shovein1, Vimalanand S Prabhu2, Yan Song3

  • 1Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA. Kale.Kponee-Shovein@analysisgroup.com.

Oncology and therapy
|July 12, 2025
PubMed
概括

在接受化疗的高风险子宫内膜癌患者中,无病生存率 (DFS) 可以预测整体生存率 (OS). 复发性疾病显著增加了死亡风险,强调了对新疗法的需求.